Product Information
DOXEPIN 25 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1368 per EA under NDC 59651017401. Its NADAC has been published 373 times since Jul 3, 2019.
FDA first approved this application on Mar 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651017401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211603FDA Approved
3/27/2019
TE Code
AB
On Market Since
3/27/2019
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 25 MG CAPSULE has been published 373 times since Jul 3, 2019, and over the history we have for it it has declined 66.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1368 per EA |
|---|---|
| All-time high | $0.4081 (Jul 10, 2019) |
| All-time low | $0.1216 (Nov 20, 2024) |
| 52-week high | $0.1404 |
| 52-week low | $0.1242 |
| Median price | $0.2190 |
| Average price | $0.2354 |
| Largest weekly change | +49.1% (Feb 22, 2023) |
| Weeks tracked | 373 |
| Tracking since | Jul 3, 2019 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 25 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1368 per EA (NDC 59651017401), effective Aug 19, 2026.
How has the price of DOXEPIN 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 25 MG CAPSULE has declined 66.5%. It has been tracked across 373 weekly CMS publications since Jul 3, 2019.
What are the highest and lowest recorded NADAC prices for DOXEPIN 25 MG CAPSULE?
Since Jul 3, 2019, the NADAC for DOXEPIN 25 MG CAPSULE has ranged from a low of $0.1216 (Nov 20, 2024) to a high of $0.4081 (Jul 10, 2019), with a median of $0.2190 per EA.
Are there cheaper alternatives to DOXEPIN 25 MG CAPSULE?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXEPIN 25 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXEPIN 25 MG CAPSULE?
DOXEPIN 25 MG CAPSULE (NDC 59651017401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.